Cardiovascular And Ottava To Drive ‘New Era Of Growth’ At Johnson & Johnson MedTech

First Big Medtech Out Of The Blocks Nudges $34bn Revenues in 2025

 
• By Ashley Yeo
  
Focus on higher-growth segments will dominate current year (Shutterstock)

More from Business

More from Medtech Insight